The functional consequences of this observation are not clear, as the efficacy of immune checkpoint inhibitors, such as anti-PD-1/PD-L1 therapy38, is limited for the treatment of colorectal cancer and restricted to the treatment of microsatellite instability-high (MSI-H) tumors39. Here, CD274 is linked to colorectal cancer.